No insider purchase over the last 90 days. The latest, by Park Jeffrey G, was filed 22 Nov 2017.
Every trade that managers of Diplomat Pharmacy, Inc. disclose to SEC (Form 4) is tracked on this page. Diplomat Pharmacy, Inc. has had no insider filing for more than a year; the last one goes back to 10 February 2020.
Looking back to 2016, when coverage begins, insiders filed 3 purchases and 42 sales.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2018 · cache
25 of 142 declarations
Diplomat Pharmacy, Inc. is a company specializing in the distribution of medications and healthcare management. It primarily operates in the specialty pharmacy market.
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2018 | 5.49 bn USD | -302.3 m USD | -4.07 USD | 10-K |
| Dec 2017 | 4.49 bn USD | 15.5 m USD | 0.23 USD | 10-K |
| Dec 2016 | 4.41 bn USD | 28.3 m USD | 0.42 USD | 10-K |
| Dec 2015 | 3.37 bn USD | 25.8 m USD | 0.41 USD | 10-K |
| Dec 2014 | 2.21 bn USD | 4.8 m USD | 0.11 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.